During 2020, Vera Salus Ricerca Srl (VSR) has performed a Pre-incubation Program at BioArk (Valais, Switzerland) sponsored by the Ark Foundation, which included professional training and coaching to optimize business and operational plans toward FlavOncology’s industrial development. FlavOncology is a versatile, small-molecule dug platform intended for the cure of patients with a variety of cancer types. The Ark’s program was successfully completed by VSR with the detailed definitions of strategies, goals and plans instrumental for fundraising launch and developmental achievements of FlavOncology.